- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00433355
Epstein-Barr Virus as a Possible Cause for Chronic Fatigue Syndrome
March 18, 2009 updated by: University of Mississippi Medical Center
Studies on Epstein-Barr Virus as a Possible Etiological Agent for Chronic Fatigue Syndrome
The purpose of this study is to understand what causes a continuing fatigue for a long time with a number of symptoms occurring at the same time (Chronic Fatigue Syndrome-CFS).
Epstein Barr Virus is among the group of viruses that have been associated with a continuing fatigue for a long time with a number of symptoms occurring at the same time, but the cause is still unknown.
Study Overview
Status
Completed
Conditions
Detailed Description
Epstein-Barr virus (EBV) is the etiological agent for heterophile positive infectious mononucleosis (IM).
It is also an oncogenic herpes virus associated with African Burkitt's lymphoma (BL),nasopharyngeal carcinoma (NPC) and AIDS-associated B-cell lymphomas.
EBV is also among a group of viruses that have been associated with chronic fatigue syndrome (CFS), although the etiology of CFS still remains unknown.Findings may lead to hypothesize that EBV enzymes, such as the dUTPase, have the capacity to induce immune dysregulation of the T-cell and NK cell responses and that this immune dysregulation produces immunopathology that results in the symptoms that we call CFS.
Study Type
Observational
Enrollment (Actual)
15
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Mississippi
-
Jackson, Mississippi, United States, 39216-4505
- University of Mississippi Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
18 y/o and above with history of CFS matched those without as to age and gender.
Description
Inclusion Criteria:
- Healthy adults for controls.
- Adults with chronic fatigue syndrome.
Exclusion Criteria:
- Individuals with significant medical illness in reference to immunosuppressant drug.
Note: We recruit participants in the Mississippi area who could come in our site to provide blood draw.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Gailen D Marshall, M.D., PhD, University of Mississippi Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2007
Primary Completion (ACTUAL)
August 1, 2008
Study Completion (ACTUAL)
October 1, 2008
Study Registration Dates
First Submitted
February 7, 2007
First Submitted That Met QC Criteria
February 8, 2007
First Posted (ESTIMATE)
February 9, 2007
Study Record Updates
Last Update Posted (ESTIMATE)
March 19, 2009
Last Update Submitted That Met QC Criteria
March 18, 2009
Last Verified
March 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Central Nervous System Diseases
- Nervous System Diseases
- Virus Diseases
- Infections
- Disease
- Musculoskeletal Diseases
- Muscular Diseases
- Neuromuscular Diseases
- DNA Virus Infections
- Tumor Virus Infections
- Herpesviridae Infections
- Encephalomyelitis
- Syndrome
- Fatigue
- Epstein-Barr Virus Infections
- Fatigue Syndrome, Chronic
Other Study ID Numbers
- 2006-0265
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Fatigue Syndrome
-
Oslo University HospitalCompletedAdolescent Chronic Fatigue SyndromeNorway
-
Shanghai University of Traditional Chinese MedicineShanghai Yueyang Integrated Medicine HospitalRecruiting
-
Ho Cheol Shin, M.D., Ph.D.Green Cross Corporation; Ajou University School of Medicine; SymyooCompletedChronic Fatigue Syndrome | Idiopathic Chronic FatigueKorea, Republic of
-
King Saud UniversityCompletedChronic Fatigue Syndrome (CFS)
-
Stony Brook UniversityCompletedChronic Fatigue Syndrome | Medically Unexplained Chronic FatigueUnited States
-
AIM ImmunoTech Inc.Temporarily not available
-
University of SevilleActive, not recruitingPost COVID Syndrome | Chronic Fatigue Syndrome/ Myalgic Encephalitis (CFS/ME)Spain
-
Center for Health Sciences, SerbiaActive, not recruitingChronic Fatigue Syndrome
-
Power Life Sciences Inc.Not yet recruitingChronic Fatigue SyndromeUnited States
-
King's College LondonSouth London and Maudsley NHS Foundation TrustNot yet recruiting